HomeCompareWENAW vs RYLD

WENAW vs RYLD: Dividend Comparison 2026

WENAW yields 5063.29% · RYLD yields 12.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 WENAW wins by $70304199583247.84M in total portfolio value
10 years
WENAW
WENAW
● Live price
5063.29%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$70304199583247.88M
Annual income
$67,674,944,133,659,165,000.00
Full WENAW calculator →
RYLD
RYLD
● Live price
12.14%
Share price
$14.95
Annual div
$1.81
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.5K
Annual income
$2,587.35
Full RYLD calculator →

Portfolio growth — WENAW vs RYLD

📍 WENAW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodWENAWRYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, WENAW + RYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
WENAW pays
RYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

WENAW
Annual income on $10K today (after 15% tax)
$430,379.75/yr
After 10yr DRIP, annual income (after tax)
$57,523,702,513,610,285,000.00/yr
RYLD
Annual income on $10K today (after 15% tax)
$1,031.60/yr
After 10yr DRIP, annual income (after tax)
$2,199.25/yr
At 15% tax rate, WENAW beats the other by $57,523,702,513,610,285,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of WENAW + RYLD for your $10,000?

WENAW: 50%RYLD: 50%
100% RYLD50/50100% WENAW
Portfolio after 10yr
$35152099791623.96M
Annual income
$33,837,472,066,829,582,000.00/yr
Blended yield
96.26%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

WENAW buys
0
RYLD buys
0
No recent congressional trades found for WENAW or RYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricWENAWRYLD
Forward yield5063.29%12.14%
Annual dividend / share$2.00$1.81
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$70304199583247.88M$44.5K
Annual income after 10y$67,674,944,133,659,165,000.00$2,587.35
Total dividends collected$70126381934526.08M$18.8K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: WENAW vs RYLD ($10,000, DRIP)

YearWENAW PortfolioWENAW Income/yrRYLD PortfolioRYLD Income/yrGap
1← crossover$517,029$506,329.11$11,914$1,213.65+$505.1KWENAW
2$25,019,286$24,466,064.78$14,099$1,351.30+$25.01MWENAW
3$1,133,242,195$1,106,471,558.74$16,580$1,494.55+$1133.23MWENAW
4$48,051,212,061$46,838,642,912.48$19,384$1,642.61+$48051.19MWENAW
5$1,907,518,068,513$1,856,103,271,607.74$22,535$1,794.70+$1907518.05MWENAW
6$70,903,526,356,852$68,862,482,023,543.80$26,063$1,950.00+$70903526.33MWENAW
7$2,468,069,984,799,694$2,392,203,211,597,861.50$29,995$2,107.69+$2468069984.77MWENAW
8$80,463,110,629,918,740$77,822,275,746,183,060.00$34,361$2,266.99+$80463110629.88MWENAW
9$2,457,248,083,727,765,000$2,371,152,555,353,752,000.00$39,194$2,427.12+$2457248083727.73MWENAW
10$70,304,199,583,247,880,000$67,674,944,133,659,165,000.00$44,525$2,587.35+$70304199583247.84MWENAW

WENAW vs RYLD: Complete Analysis 2026

WENAWStock

Anew Medical, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic partnership with Japan's Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases. Anew Medical, Inc. is based in Omaha, Nebraska.

Full WENAW Calculator →

RYLDETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →
📬

Get this WENAW vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

WENAW vs SCHDWENAW vs JEPIWENAW vs OWENAW vs KOWENAW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.